Guardant Health Newsroom

Guardant Health Initiated at Overweight by Barclays

Dow Jones12:16 ET · Ratings

Guardant Health Presents Phase II NEO Trial Data On Guardant Reveal Tool For Organ Preservation In Node-Negative Rectal Cancer At The ASCO GI Symposium

BenzingaJan 23 08:18 ET

Guardant Health to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development

BusinesswireJan 23 08:05 ET

Barclays Initiates Guardant Health(GH.US) With Buy Rating, Announces Target Price $60

Moomoo NewsJan 23 07:33 ET · Ratings

Guardant Health's Strategic Growth: Strong Buy Rating Amid Advancements in Reveal MRD Assay

TipRanksJan 23 05:06 ET

Why Guardant Health, Inc. (GH) Soared At The Start Of The Trading Week

Yahoo FinanceJan 22 12:04 ET

Guardant Health Analyst Ratings

BenzingaJan 22 10:54 ET · Ratings

Guardant Health (GH) Receives a Buy From Craig-Hallum

TipRanksJan 22 08:45 ET · Ratings

A Quick Look at Today's Ratings for Guardant Health(GH.US), With a Forecast Between $39 to $55

Moomoo NewsJan 22 08:00 ET · Ratings

Guardant Health Up Over 22%, on Pace for Largest Percent Increase Since March 2019 -- Data Talk

Dow JonesJan 21 14:51 ET

Guardant Health's Strategic Milestones and Medicare Coverage Drive Buy Rating With $55 Price Target

TipRanksJan 21 12:05 ET · Ratings

Guardant Health Price Target Raised to $55 From $50 at BTIG

TipRanksJan 21 11:55 ET

Guardant Stock Jumps 12% on Medicare Coverage Expansion

Seeking AlphaJan 21 10:09 ET

Guardant Health Receives Medicare Coverage for Guardant Reveal on Smart Liquid Biopsy Platform for Surveillance Testing in Colorectal Cancer Patients

BusinesswireJan 21 08:05 ET

Guardant Health, ConcertAI Collaborate On Agreement That Allows Biopharmaceutical Companies To Access The First Multi-Modal Real-World Data That Integrates Comprehensive Patient Electronic Medical Record Data With Both Genomic And Epigenomic Tumor...

BenzingaJan 16 08:15 ET

Express News | Guardant Health Inc - Financial Terms of Agreement Not Disclosed

ReutersJan 16 08:05 ET

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development

BusinesswireJan 16 08:05 ET

Express News | Guardant Health, Concertai Collaborate to Form First Data-as-a-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development

ReutersJan 16 08:05 ET

Express News | Viz.ai to Collaborate With Guardant Health to Improve Lung Cancer Detection, Diagnosis, and Treatment

ReutersJan 14 15:58 ET

Express News | Viz.ai Reveals Proposed Collaboration With Guardant Health

BenzingaJan 14 15:57 ET